← Back to Search

Primary reverse for Shoulder Osteoarthritis

N/A
Recruiting
Research Sponsored by Smith & Nephew, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

The goal of this study is to confirm the safety and performance of the AETOS Shoulder System for USA adoption. This is a prospective, open, adaptive, non-comparative, multi-centre investigation enrolling a maximum of 220 subjects in 2 cohorts (anatomic and reverse) at up to 15 sites. No intra-study comparator group will be included, and there will be no randomization

Eligible Conditions
  • Shoulder Osteoarthritis
  • Shoulder Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Implant Survivorship
Secondary outcome measures
American Shoulder and Elbow Score (ASES)
Constant Murley Score
Implant Survivorship at 6 months, 1 year, 3.5 years and 5 years
+11 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Primary reverseExperimental Treatment1 Intervention
Those subjects who have AETOS implanted in the Reverse configuration
Group II: Primary AnatomicExperimental Treatment1 Intervention
Those subjects who have the AETOS implanted in the Primary Anatomic configuration

Find a Location

Who is running the clinical trial?

Smith & Nephew, Inc.Lead Sponsor
165 Previous Clinical Trials
22,261 Total Patients Enrolled
Kolja BoeseStudy DirectorSmith & Nephew, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~147 spots leftby Aug 2027